Astellas Pharma Inc. Site Map
 
Home > News Room > News Releases
   
News Releases

Archives: Search / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002 / 2001

Jul 16, 2014
If isavuconazole is approved for invasive candidiasis, QIDP status provides a five-year extension of market exclusivity.
Jun 24, 2014
- Uhlendorf is leaving his current position as Vice President, Communications and Public Affairs at PhRMA -
May 14, 2014
Eight abstracts will highlight enzalutamide studies in prostate and breast cancers
Apr 16, 2014
- Bloss to serve on Astellas US Management Committee -
 

   
Copyright © 2005 - 2014 Astellas Pharma US, Inc. Site Map  Privacy Policy  Legal Disclaimer  Contact Us